scholarly journals Quantitative estimation of the liver parenchymal echopattern using acoustic intensive histogram(Echo-histogram) analysis in diffuse liver diseases.

1989 ◽  
Vol 78 (3) ◽  
pp. 331-337
Author(s):  
Shunichi KIMURA
Keyword(s):  
Liver Diseases ◽  
Quantitative Estimation ◽  
Histogram Analysis ◽  
Liver Parenchymal ◽  
Diffuse Liver Diseases

Density Histogram Analysis of Unenhanced Hepatic Computed Tomography in Patients With Diffuse Liver Diseases

2006 ◽  
Vol 30 (2) ◽  
pp. 201-205 ◽  
Author(s):  
Gerald A. Fritz ◽  
Helmut Schoellnast ◽  
Hannes A. Deutschmann ◽  
Marco Wiltgen ◽  
Peter Brader ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Liver Diseases ◽  
Histogram Analysis ◽  
Density Histogram ◽  
Diffuse Liver Diseases

scholarly journals Visual Signs of Chronic Diffuse Liver Diseases: the Stigma of Skin, its Appendages and Mucous Membranes

2013 ◽  
Vol 3 (3) ◽  
pp. 18-30
Author(s):  
M. Abrahamovych ◽  
◽  
O. Abrahamovych ◽  
O. Fayura ◽  
◽  
...  
Keyword(s):  
Liver Diseases ◽  
Mucous Membranes ◽  
Diffuse Liver Diseases

Neural Networks for the Echographic Diagnosis of Diffuse Liver Diseases

ICANN ’93 ◽  
1993 ◽  
pp. 948-948
Author(s):  
J. M. Thijssen ◽  
H. J. Huisman ◽  
M. S. klein Gebbink ◽  
J. T. M. Verhoeven ◽  
T. E. Schouten
Keyword(s):  
Neural Networks ◽  
Liver Diseases ◽  
Diffuse Liver Diseases

Multislice computer tomography perfusion imaging of the hepatosplenic zone in patients with diffuse liver diseases

Pharmateca ◽  
2019 ◽  
Vol 2_2019 ◽  
pp. 42-47
Author(s):  
E.A. Mezikova Mezikova ◽  
V.D. Zavadovskaya Zavadovskaya ◽  
E.V. Beloborodova Beloborodova ◽  
I.V. Dolgalev Dolgalev ◽  
O.S. Tonkikh Tonkikh ◽  
...  
Keyword(s):  
Computer Tomography ◽  
Perfusion Imaging ◽  
Liver Diseases ◽  
Multislice Computer Tomography ◽  
Diffuse Liver Diseases

scholarly journals Microstructural Changes in Hepatocytes against a Background of Liver Fibrosis in Patients with Chronic Diffuse Liver Diseases

2016 ◽  
Vol 0 (1.59) ◽  
pp. 66 ◽  
Author(s):  
Yu.M. Stepanov ◽  
Yu.A. Haidar ◽  
V.I. Didenko ◽  
O.P. Halenko ◽  
N.Yu. Oshmyanska
Keyword(s):  
Liver Fibrosis ◽  
Liver Diseases ◽  
Microstructural Changes ◽  
Diffuse Liver Diseases

scholarly journals Features of management of patients with liver diseases in the conditions of the COVID-19 pandemic

2021 ◽  
Vol 40 (3) ◽  
pp. 57-62
Author(s):  
Yuriy A. Kravchuk
Keyword(s):  
Liver Cirrhosis ◽  
Liver Damage ◽  
Liver Diseases ◽  
Intestinal Barrier ◽  
The Elderly ◽  
Right Ventricular Failure ◽  
Ventricular Failure ◽  
Decompensated Liver Cirrhosis ◽  
Diffuse Liver Diseases ◽  
Alanine Aminotransferase Activity

Liver dysfunction is common with COVID-19 infection, and the prevalence is higher in men as well as in the elderly. Manifestations of liver damage such as high aspartate aminotransferase and alanine aminotransferase activity, increased bilirubin levels, low albumin levels, and prolonged prothrombin time are associated with severe COVID-19 infection. Mortality in patients with diffuse liver diseases without cirrhosis with COVID-19 infection was 12 %, in the presence of liver cirrhosis up to 40%, decompensated liver cirrhosis up to 4363%. The mechanisms of liver damage in COVID-19 include direct hepatotoxicity and indirect liver damage (due to systemic inflammation with impaired immunity, sepsis, hypoxia, ischemia, coagulopathy, endotheliitis, right ventricular failure, worsening of the course of existing liver diseases, drug liver damage). Treatment of patients with diffuse liver diseases includes lifestyle and nutritional modification, the use of hepatoprotective drugs, and means of correcting the intestinal barrier (bibliography: 30 refs).

Sign in / Sign up

Export Citation Format

Share Document